Phase III prospective randomized trial of Dose-Esclated Radiotherapy with or without short-term adrogen deprivation therapy for patients with Intermediate-Risk prostate cancer.

Phase III trial of Dose-Esclated Radiation Therapy and standard androgen deprivation therapy (ADT) with a GNRH agonist versus Dose-Esclated Radiation Therapy and enhanced ADT with a GNRH agonist and TAK-700 for men with High Risk Prostate cancer.

A Phase III trial of short term androgen deprivation with pelvic node or prostate bed only radiotherapy. (SPORT) in Protate Cancer patients with risking PSA after radical prostatectomy.

A Phase III randomized trial: Androgen deprivation therapy and High-Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate cancer.